Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
What Are the Biomarkers for Immunotherapy in SCLC?
Longo V, Catino A, Montrone M, Pizzutilo P, Annese T, Pesola F, Marech I, Cassiano S, Ribatti D, Galetta D. Longo V, et al. Among authors: pesola f. Int J Mol Sci. 2021 Oct 15;22(20):11123. doi: 10.3390/ijms222011123. Int J Mol Sci. 2021. PMID: 34681779 Free PMC article. Review.
EPSILoN: A Prognostic Score Using Clinical and Blood Biomarkers in Advanced Non-Small-cell Lung Cancer Treated With Immunotherapy.
Prelaj A, Rebuzzi SE, Pizzutilo P, Bilancia M, Montrone M, Pesola F, Longo V, Del Bene G, Lapadula V, Cassano F, Petrillo P, Bafunno D, Varesano N, Lamorgese V, Mastrandrea A, Ricci D, Catino A, Galetta D. Prelaj A, et al. Among authors: pesola f. Clin Lung Cancer. 2020 Jul;21(4):365-377.e5. doi: 10.1016/j.cllc.2019.11.017. Epub 2020 Mar 7. Clin Lung Cancer. 2020. PMID: 32245624 Clinical Trial.
DiM: Prognostic Score for Second- or Further-line Immunotherapy in Advanced Non-Small-Cell Lung Cancer: An External Validation.
Prelaj A, Lo Russo G, Proto C, Signorelli D, Ferrara R, Galli G, De Toma A, Randon G, Pagani F, Trevisan B, Ganzinelli M, Zilembo N, Montrone M, Longo V, Pesola F, Pizzutilo P, Del Bene G, Varesano N, Galetta D, Torri V, Garassino MC, Di Maio M, Catino A. Prelaj A, et al. Among authors: pesola f. Clin Lung Cancer. 2020 Sep;21(5):e337-e348. doi: 10.1016/j.cllc.2020.01.005. Epub 2020 Mar 7. Clin Lung Cancer. 2020. PMID: 32291212 Free article.
Smoking Prevalence, Knowledge and Perceptions on Tobacco Control Among Healthcare Professionals: A Survey in an Italian Cancer Center.
Bafunno D, Catino A, Lamorgese V, Longo V, Montrone M, Pesola F, Pizzutilo P, Petrillo P, Varesano N, Zacheo A, Del Bene G, Lapadula V, Mastrandrea A, Ricci D, Di Lauro A, Cassiano S, Galetta D. Bafunno D, et al. Among authors: pesola f. J Community Health. 2021 Jun;46(3):597-602. doi: 10.1007/s10900-020-00907-8. J Community Health. 2021. PMID: 32789714
Incidence of Infections and Predictors of Mortality During Checkpoint Inhibitor Immunotherapy in Patients With Advanced Lung Cancer: A Retrospective Cohort Study.
Bavaro DF, Pizzutilo P, Catino A, Signorile F, Pesola F, Di Gennaro F, Cassiano S, Marech I, Lamorgese V, Angarano G, Monno L, Saracino A, Galetta D. Bavaro DF, et al. Among authors: pesola f. Open Forum Infect Dis. 2021 Apr 13;8(6):ofab187. doi: 10.1093/ofid/ofab187. eCollection 2021 Jun. Open Forum Infect Dis. 2021. PMID: 34141817 Free PMC article.
Esophageal Stricture Caused by ALK-Positive NSCLC Esophageal Metastasis Resolved After a Few Days of Lorlatinib Therapy Without Stent Placement.
Longo V, Catino A, Montrone M, Pizzutilo P, Ugenti I, Lacalamita R, Del Bene G, Pesola F, Marech I, Galetta D. Longo V, et al. Among authors: pesola f. JTO Clin Res Rep. 2020 Apr 18;1(2):100044. doi: 10.1016/j.jtocrr.2020.100044. eCollection 2020 Jun. JTO Clin Res Rep. 2020. PMID: 34589934 Free PMC article. No abstract available.
76 results